{"transactions":[{"id":1425904,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88096,"kind":"person","name":"Myers Thomas Richard","position":1,"cik":"0001755512","reported_name":"Myers Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec VP, Tech & Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-22T22:06:44.000Z","date":"2024-08-20","kind":"grant","planned":false,"acquired":true,"shares":155000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable in four equal installments on November 20, 2024, February 20, 2025, May 20, 2025, and August 20, 2025."}],"balance_after":155000,"derivative":{"exercise_price":0.07,"expiration_date":"2034-08-20","underlying":"Common Stock","underlying_shares":155000},"source":{"system":"sec-edgar","filing":"0001493152-24-033624","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000149315224033624/ownership.xml","form_type":"4"}},{"id":1816969,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88096,"kind":"person","name":"Myers Thomas Richard","position":1,"cik":"0001755512","reported_name":"Myers Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-03T20:20:16.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable in four equal installments on November 1, 2023, February 1, 2024, May 1, 2024, and August 1, 2024."}],"balance_after":150000,"derivative":{"exercise_price":0.12,"expiration_date":"2033-08-01","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-23-044431","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919123044431/doc4.xml","form_type":"4"}},{"id":2145771,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88096,"kind":"person","name":"Myers Thomas Richard","position":1,"cik":"0001755512","reported_name":"Myers Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-04T20:27:11.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shares shall vest and become exercisable in four equal installments December 30, 2022, March 30, 2023, June 30, 2023, and September 30, 2023."}],"balance_after":125000,"derivative":{"exercise_price":0.2,"expiration_date":"2032-09-30","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-22-052235","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919122052235/doc4.xml","form_type":"4"}},{"id":2145770,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88096,"kind":"person","name":"Myers Thomas Richard","position":1,"cik":"0001755512","reported_name":"Myers Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-04T20:27:11.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2023 or January 15, 2023 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2024 or January 15, 2024."}],"balance_after":125000,"derivative":{"exercise_price":0.2,"expiration_date":"2032-09-30","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-22-052235","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919122052235/doc4.xml","form_type":"4"}},{"id":2659476,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88096,"kind":"person","name":"Myers Thomas Richard","position":1,"cik":"0001755512","reported_name":"Myers Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-23T00:25:48.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shares shall vest and become exercisable in four equal installments on September 18, 2021, December 18, 2021, March 18, 2022 and June 18, 2022."}],"balance_after":125000,"derivative":{"exercise_price":0.45,"expiration_date":"2031-06-18","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-21-042595","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919121042595/doc4.xml","form_type":"4"}},{"id":2659475,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88096,"kind":"person","name":"Myers Thomas Richard","position":1,"cik":"0001755512","reported_name":"Myers Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-23T00:25:48.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2022 or January 15, 2022 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2023 or January 15, 2023."}],"balance_after":100000,"derivative":{"exercise_price":0.45,"expiration_date":"2031-06-18","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-21-042595","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919121042595/doc4.xml","form_type":"4"}},{"id":3103458,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88096,"kind":"person","name":"Myers Thomas Richard","position":1,"cik":"0001755512","reported_name":"Myers Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common stock","published_at":"2020-06-22T22:45:31.000Z","date":"2020-05-01","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of restricted stock units (the \"RSUs\"). 33.3% of the RSUs vest on May 1, 2021 with the remaining shares vesting in 2 equal annual installments thereafter.  Vested shares will be delivered to the Reporting Person on the earlier of (i) the ten-year anniversary of the date of grant (May 1, 2020); (ii) sixty days after the date the Reporting Person's service with the Issuer ceases for any reason and such cessation constitutes a \"separation from service\" within the meaning of Section 409A of the Code; (iii) the date of the Reporting Person's death or (iv) the date of a Change in Control (as defined in the RSU) that constitutes a \"change in control event\" within the meaning of Section 409A of the Code."}],"balance_after":587500,"source":{"system":"sec-edgar","filing":"0001209191-20-038300","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120038300/doc4.xml","form_type":"4"}},{"id":3143670,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88096,"kind":"person","name":"Myers Thomas Richard","position":1,"cik":"0001755512","reported_name":"Myers Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-05-19T23:02:31.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable in four equal installments on August 15, 2020, November 15, 2020, February 15, 2021 and May 15, 2021."}],"balance_after":125000,"derivative":{"exercise_price":0.79,"expiration_date":"2030-05-15","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-20-030699","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120030699/doc4.xml","form_type":"4"}},{"id":3297038,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88096,"kind":"person","name":"Myers Thomas Richard","position":1,"cik":"0001755512","reported_name":"Myers Thomas Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-01T01:42:11.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable in eight equal quarterly installments beginning on April 30, 2020."}],"balance_after":125000,"derivative":{"exercise_price":0.33,"expiration_date":"2030-01-29","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-20-005911","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120005911/doc4.xml","form_type":"4"}}]}